Phase 1 ADHD Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)
Attention Deficit Hyperactivity Disorder (ADHD)
Universidade do Sul de Santa Catarina60 enrolled1 locationNCT07592390
Recruiting
Phase 1
Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
Cognitive ImpairmentSickle Cell DiseaseAttention Deficit Hyperactivity Disorder (ADHD)+1 more
St. Jude Children's Research Hospital72 enrolled1 locationNCT07226219
Recruiting
Phase 1
A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
ADHD
Otsuka Pharmaceutical Development & Commercialization, Inc.42 enrolled1 locationNCT07314333
Recruiting
Phase 1Phase 2
Dual-target iTBS for Youth With ADHD
ADHD
Shanghai Mental Health Center15 enrolled1 locationNCT07084649
Completed
Phase 1
Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy Volunteers
Attention Deficit Hyperactivity Disorder (ADHD)
Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.20 enrolled1 locationACTRN12613001073796